TBTeresa Bas

Teresa Bas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Teresa Bas has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A fully autonomous AI system for accurate and reproducible Cobb angle measurement in adolescent idiopathic scoliosis: a multicenter study

    by Germán Casabó-Vallés, Rodrigo Aldecoa, Gisselle Pérez-Machado, Rosa M Egea-Gámez, Judith Sánchez-Raya, Inma Vilalta-Vidal, Pedro A Rubio-Belmar, María Galán-Olleros, Judith Salat-Batlle, Carles Fabrés Martín, et al.


  • Open Access

    Cor-Esc-25: A Low-Cost Prototype for Monitoring Brace Adherence and Pressure in Adolescent Idiopathic Scoliosis

    by Pablo Ulldemolins, Pedro Rubio, Jorge Morales, Silvia Pérez, Jose Luis Bas, Paloma Bas, Mario Lamas, Jose María Baydal, Miquel Bovea, Carlos María Atienza, et al.

    The treatment of adolescent idiopathic scoliosis (AIS) requires the use of orthopedic braces. However, few current designs provide real-time monitoring or inform clinicians about the precise adjustment of therapeutic pressure. The objective of this study is to develop a low-cost open-system prototype capable of providing future researchers with objective information regarding brace adherence and adjustment. For adherence evaluation, a market study was conducted to identify temperature-measuring devices and a custom system was developed to measure adjustment. Cor-Esc-25 was developed to monitor brace adherence using a non-invasive temperature sensor which connects via Bluetooth to the parents’ smartphone, which runs an app that uploads the data to an online platform accessible to clinicians. In addition, a custom-designed pressure sensing device was created. This system uses three patches connected to an acquisition board and are installed on the brace each time the patient visits the clinic. It connects to a customized application where clinicians can view all the information. Cor-Esc-25 represents a first step toward the creation of personalized consultations, where AIS treatment monitoring is based on objective criteria that consider both adherence and brace adjustment. Its design allows for easy integration into clinical settings, thereby improving the ability of researchers and clinicians to assess the effectiveness of brace treatment.


  • Open Access

    Evaluation of the Efficacy of the Addition of a Combination of Pyrimidine Nucleotides and Vitamin B1 and B12 to Standard Treatment in the Management of Painful Radiculopathy and in the Quality of Life of Patients

    by Jordi Monfort, Irene Carrión-Barberà, Laura Tío, Javier Marante, Alicia López Vázquez, Teresa Bas, Lola Fernandez-Fuente-Burson, Miguel A. Caracuel, Antonio Oliveros-Cid, Virginia Gallart, et al.

    Background/Objectives: Radiculopathy leads to pain, consequently reducing patient’s quality of life (QoL). Research indicates that certain nucleotides, such as cytidine and uridine, along with vitamins B1 and B12, may help alleviate pain and enhance QoL. This study assessed the impact of adding a supplement containing cytidine and uridine nucleotides and vitamins B1 and B12, alongside standard treatment, on radiculopathy-associated pain. Methods: A multicenter, prospective, two-cohort, randomized, open-label study was conducted. The control group received standard treatment, while the experimental group received standard treatment plus the supplement. The primary endpoint was pain reduction measured by a Visual Analog Scale (VAS). Secondary endpoints included functional improvement (Roland Morris questionnaire), clinical improvement (Clinical Global Impression [CGI] scale), and QoL improvement (EQ-5D-5L questionnaire). Results: A total of 122 patients were included from 17 centers across Spain. Both groups showed pain improvement, but the VAS reduction (control: 24.58 vs. experimental: 31.35) was not statistically significant. The Roland Morris score decreased significantly in the experimental group (estimate: −1.70, 95% CI −3.29 to −0.10; p = 0.038), and these patients were 5 times more likely to progress to a better CGI category (OR = 0.20, 95% CI 0.07 to 0.57; p = 0.003). No significant differences were observed in EQ-5D-5L scores or analgesic consumption. Conclusions: The addition of supplemental pyrimidine nucleotides and vitamins B1 and B12 to standard of care treatment improved radiculopathy functional and clinical outcomes. Regarding pain, however, although there was a numerical improvement, it did not reach statistical significance.


  • Open Access

    Efficacy and Safety of Intravenous Magnesium Sulfate in Spinal Surgery: A Systematic Review and Meta-Analysis

    by Jorge Campos, Jose Luis Bas, Claudia Campos, Gonzalo Mariscal, Teresa Bas, Paloma Bas

    Optimizing pain management in spinal surgery is crucial for preventing adverse events due to delayed mobilization. Magnesium sulfate has potential benefits in spinal surgery because of its analgesic properties and modulation of neurotransmitters and autonomic nervous system. Existing evidence regarding the use of magnesium sulfate is partial and controversial, necessitating a comprehensive meta-analysis to evaluate its efficacy and safety. The aim of this study was to conduct a comprehensive meta-analysis to evaluate the efficacy and safety of magnesium sulfate in spinal surgery compared to other available options. This meta-analysis adhered to the PRISMA guidelines. Patients undergoing spinal surgery were included, with the intervention group receiving intravenous magnesium sulfate (MS) at various doses or combinations, whereas the comparison group received other alternatives or a placebo. The efficacy and safety outcomes were assessed. Data were collected from multiple databases and analyzed using Review Manager version 5.4. Heterogeneity was assessed and fixed- or random-effects models were applied. The meta-analysis included eight studies (n = 541). Magnesium sulfate demonstrated significant reductions in pain at 24 h (MD −0.20, 95% CI: −0.39 to −0.02) and opioid consumption (SMD −0.66, 95% CI: −0.95 to −0.38) compared to placebo. Additionally, a decrease in the use of muscle relaxants (SMD −0.91, 95% CI: −1.65 to −0.17) and remifentanil (SMD −1.52, 95% CI: −1.98 to −1.05) was observed. In contrast, an increase in extubation time (MD 2.42, 95% CI: 1.14 to 3.71) and verbal response (MD 1.85, 95% CI: 1.13 to 2.58) was observed compared to dexmedetomidine. In conclusion, magnesium sulfate administration in spinal surgery reduced pain and opioid consumption, and prolonged orientation and verbal response. No significant differences in blood pressure or heart rate were observed between the groups.


  • Escoliosis idiopática: ideas clave del tratamiento conservador

    by Amparo Ortega Yago, Fernando Bonilla Enseñat, Elena Sáez Padilla, Teresa Bas Hermida

    La escoliosis es una deformidad del raquis con una curvatura en plano coronal (≥ 10º) , con área de rotación fija (plano axial) y tendencia a hipocifosis (plano sagital) sin causa conocida. Comprende el 80% de las escoliosis y supone una prevalencia del 3% de la población. Lo primero que debemos hacer siempre, es una historia clínica detallada. Es importante descartar la presencia de “red flags”. La valoración del Risser y Sanders permite determinar las probabilidades de progresión de la curva. El tratamiento con corsé se inicia ante la presencia de curva mayor a 25º, es eficaz, y es dependiente de las horas que lo lleve el paciente. Es importante un correcto seguimiento estrecho durante toda la etapa de crecimiento hasta la madurez esquelética completa del paciente.

  • Open Access

    The Global Spine Care Initiative: methodology, contributors, and disclosures

    by Claire D. Johnson, Scott Haldeman, Margareta Nordin, Roger Chou, Pierre Côté, Eric L. Hurwitz, Bart N. Green, Deborah Kopansky-Giles, Kristi Randhawa, Christine Cedraschi, et al.

    The purpose of this report is to describe the Global Spine Care Initiative (GSCI) contributors, disclosures, and methods for reporting transparency on the development of the recommendations.


  • Late neurological complications due to laminar hook compression in idiopathic scoliosis surgery

    by Albert Ferrando, Paloma Bas, Teresa Bas

    To provide a review of unusual neurological complications occurring years after spinal instrumentation surgery. The authors analyzed the cases of three patients with adolescent idiopathic scoliosis who presented with delayed neurological symptoms (later than 12 months postoperatively) following spinal deformity surgery using Texas Scottish Rite Hospital (TSRH) hook-rod instrumentation. One case presented with conus medullaris syndrome while the last two were rare cases of posterior cord syndrome due to a dislodged laminar hook at the thoracolumbar transition. In all three cases, the neurological symptoms were due to direct laminar hook compression. Metallosis was observed extra-spinally around the hook-rod construct but not at the sublaminar site. The dislodged laminar hook responsible for the symptoms was situated at the concavity of the curve with the blade-tip pointing downwards. Symptomatic improvement was observed in all patients following complete hardware removal. Conscientious long-term follow-up of patients undergoing posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS) is important in order to recognize late neurological deficits directly related to instrumentation. Anamnesis and physical examination are key for initial assessment and diagnosis, while myelography and computed tomography (CT) images are of great help to confirm the site of spinal compression. Removal of the dislodged laminar hooks after PSF with TSRH instrumentation in AIS cases can potentially improve neurological symptoms.


  • Chronic infections of the Spine

    by Teresa Bas, Paloma Bas, Alejandro Blasco, José Luis Bas

    Chronic infections following posterior fusion are relatively uncommon. They develop in a previous asymptomatic patient at a distant time from the surgery. Chronic infections arise from direct inoculation or hematogenous seeding. To eradicate a chronic infection, the pathogens, biofilm, non-viable tissues, adherence on surfaces, and instrumentation must be removed. The appropriate antibiotherapy is used in a short (4 weeks) or long protocol (9 weeks). Some patients may need repeated surgeries (leaving the instrumentation in situ) to avoid progressive deformity or symptomatic pseudoarthrosis in cases of implant removal.